(2012) 26, 418-426 “
“The whitefly Bemisia tuberculata has c

(2012) 26, 418-426.”
“The whitefly Bemisia tuberculata has caused

serious damage to cassava producing areas in the state of Mato Grosso do Sul. However, little is known about the biological characteristics of this species. The objective of this study was therefore, to monitor the development of this species bred on cassava plants under controlled greenhouse conditions, and to determine its most vulnerable stages and its reproductive capacity, as well as measuring the length and width each stage of development. To obtain these data, adult individuals were kept in voile traps on cassava leaves of five different plants, totalling ten leaves. After 24 hours the leaves were CT99021 clinical trial removed from the traps thus making each egg-laden leaf an experimental unit. The lowest mortality rate was record in the last nymphal stage (‘pupae) compared with the other development stages. The highest mortality occurred in the nymphs at the 2nd and 3rd instars. Each female laid an average learn more of 6.3 eggs in 24 hours. Thirteen days after egg laying, every one of the nymphs was fixed on the leaves of cassava plants. From the egg laying stage up until the adult stage, the process took 26 days. The proportion of females was 73.5%. The average size of the B. tuberculata egg was 163.22 mu m in length and 72.39 mu m in width and the “pupae” is 915.82 mu m in length and 628.71 mu m in width. The measurements of males were 797.16 mu m in length and 200.81 mu m

in width and the length females 916.12 mu m in length and 338.99 mu m in width. The parasitoid Encarsia porteri (Mercet, 1928) (Hymenoptera, Aphelinidae) was found in the insect stock culture.”
“This review provides an update on the most recent data on mortality in people with gout. A large prospective study among men found that those with gout have a higher risk of death from all causes. Among men who did not have pre-existing coronary heart disease,

the increased SYN-117 mortality risk is due primarily to an elevated risk of cardiovascular death, particularly from coronary heart disease. Also, an extension study of a large clinical trial among men with above-average risk for coronary heart disease found that a diagnosis of gout accompanied by an elevated uric acid level is associated with increased long-term (approximately 17 years) risk of all-cause mortality that arises largely from an increased risk of cardiovascular disease (CVD) mortality. Although limited, these emerging data suggest that men with gout have a higher risk of death from all causes and the increased mortality risk is primarily due to an elevated risk of CVD death. These findings would provide support,for the aggressive management of cardiovascular risk factors in men with gout. More data that adjust comprehensively for various associated CVD markers are needed to reinforce this concept. Furthermore, given apparent potential sex differences in gout epidemiology and its risk factors, prospective studies specifically among women would be valuable.

Comments are closed.